Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9352789 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL13004403 | 0.85 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL24490717 | 0.83 | — | — | |
| Water SCHEMBL28173589 | 0.83 | — | — | |
| SCHEMBL20007953 | 0.83 | — | — | |
| SCHEMBL2293158 | 0.78 | — | — | |
| SCHEMBL5013498 | 0.77 | EPHX1 (0.32) | ALDH1A1 | |
| SCHEMBL5090317 | 0.72 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL2319153 | 0.71 | — | — | |
| SCHEMBL27271966 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3421586-B1 | IMMOBILIZED ENYMATIC REACTOR | WATERS TECHNOLOGIES CORP (US) | 2021-10-27 | — | — | EP | disclosed |
| US-20210239655-A1 | DEVICE AND METHODS FOR PERFORMING SIZE EXCLUSION CHROMATOGRAPHY | WATERS TECHNOLOGIES CORPORATION (US) | 2021-08-05 | — | — | US | disclosed |
| US-20200216873-A1 | IMMOBILIZED ENZYMATIC REACTOR | WATERS TECHNOLOGIES CORPORATION (US) | 2020-07-09 | — | — | US | disclosed |
| EP-3421586-A2 | IMMOBILIZED ENYMATIC REACTOR | Waters Technologies Corporation (US) | 2019-01-02 | — | — | EP | disclosed |
| US-20180171379-A1 | IMMOBILIZED ENZYMATIC REACTOR | WATERS TECHNOLOGIES CORPORATION | 2018-06-21 | — | — | US | disclosed |
| US-20180171379-A1 | IMMOBILIZED ENZYMATIC REACTOR | WATERS TECHNOLOGIES CORPORATION | 2018-06-21 | — | — | US | disclosed |
| US-9890411-B2 | Immobilized enzymatic reactor | WATERS TECHNOLOGIES CORPORATION (US) | 2018-02-13 | — | — | US | disclosed |
| US-9890411-B2 | Immobilized enzymatic reactor | WATERS TECHNOLOGIES CORPORATION (US) | 2018-02-13 | — | — | US | disclosed |
| US-20140162298-A1 | IMMOBILIZED ENZYMATIC REACTOR | WATERS TECHNOLOGIES CORPORATION (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140162298-A1 | IMMOBILIZED ENZYMATIC REACTOR | WATERS TECHNOLOGIES CORPORATION (US) | 2014-06-12 | — | — | US | disclosed |
| US-7312205-B2 | Methods and compositions for inhibiting tumor growth | NOVELIX PHARMACEUTICALS, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-7291713-B2 | Branched polyalkylene glycols | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-11-06 | — | — | US | disclosed |
| US-7291713-B2 | Branched polyalkylene glycols | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-11-06 | — | — | US | disclosed |
| US-20070134163-A1 | Radiographic contrasting agents and radio-opaque polymeric materials for medical devices | CORDIS US CORP | 2007-06-14 | — | — | US | disclosed |
| US-5609851-A | Compounds which can be used in contrast products for radiography | GUERBET S A. (FR) | 1997-03-11 | — | — | US | disclosed |
| WO-1993016983-A1 | COMPOUNDS USED IN CONTRAST PRODUCTS FOR RADIOGRAPHY | GUERBET S.A. (FR) | 1993-09-02 | — | — | WO | disclosed |
| EP-0558395-A1 | Compounds useful in contrast agents for radiography | GUERBET S.A. (FR) | 1993-09-01 | — | — | EP | disclosed |
| US-5057425-A | Recombinant DNA cloning vector | ELI LILLY AND COMPANY (US) | 1991-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070134163-A1 | Radiographic contrasting agents and radio-opaque polymeric materials for medical devices | MYADM, PBRM1, RXFP3 | ALDH1A1 3894/4885TSHR 1324/4885 |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | RXFP1, SLC5A7, SLC40A1 | ALDH1A1 2843/4885TSHR 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.